These results show that in the absence of ATD treatment for GD hyperthyroidism, patients with GHPA combined with GD treated with TSS or SSA experienced a significant decrease in thyroid hormones along with a decrease in GH/IGF-1 levels. This evidence concerns the gene GH1 and Jeune syndrome.